SP1 and type 2 diabetes mellitus: Increased NF-κB activation in type II diabetes mellitus has also been implicated in impaired vascular function, including myogenic tone, vascular reactivity, and inflammatory response through the detection of PARP-1, SP-1, and COX-2 activity [12].